|
|
|
|
|
| September 23,
2010 | ISSUE NUMBER 167 VOL 8 |
Biosimilars
This Decade’s Most Disruptive Technology
Shakespeare said it best: To be or not to be? It’s decision time for Big Pharma on entering the biosimilar space.
Regulatory
FDA and Medicare: A Happy Future Together?
FDA’s recently announced planned project to make joint drug approval decisions with CMS could mean faster national coverage. But what’s the flip side?
New and Noteworthy
Explaining the Drug Drought
Two thought leaders in the academic research community propose a new policy agenda to identify the factors behind the slowing rate of new drug approvals and what industry must do to revive its principal role as the discoverer and development of therapies that meet real medical need.
Social Media
Social Media and Healthcare Consumers: A New Report
Just how is social media influencing pharma’s relationship with consumers, and vice versa?
|
|
 // Eli Lilly appointed Jeffrey Winton as VP, Communication; Winton assumes his role on Oct. 10. // The Japan Pharmaceutical Manufacturers Association appointed Tadaharu Goto as its new Director General. // Aquinox Pharmaceuticals (Vancouver, Canada) appointed Csaba Szabó, MD, PhD, as Vice President of Research and Chief Scientific Officer. // |
|
|
|
Release Higher Performance Through Business Analytics
Wednesday, Sept. 22, 11 A.M. Eastern; 8 A.M. Pacific
Register Free at http://pharmexec.com/analytics
3-D Segmentation: Managing your Brand’s Three Most Important Influencers
Thursday, Oct. 7, at 12 P.M. Eastern; 9 A.M. Pacific
Register Free at http://pharmexec.com/geo |
| |
|
Sep 29–30 6th Annual Bio/Pharmaceutical and Medical Device Product Recalls Summit
Washington, DC
Oct 20–21 Innovative Contracting for Bio/Pharmaceuticals
London, UK
Nov 4th SharePoint User Workshop for the Life Sciences Industry
Princeton, NJ
Dec 8–9 CMAC 2010 – Commercialization and Market Access Congress
Orlando, FL |
|
 |
|
|
|
 |
|
 |
|
 |
| Are FDA’s plans to collaborate with Medicare on drug approval decisions a good thing? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
